Previous 10 | Next 10 |
2023-12-18 16:39:51 ET More on Trinity Biotech Trinity Biotech plc (TRIB) Q2 2023 Earnings Call Transcript Financial information for Trinity Biotech For further details see: Trinity Biotech promotes finance chief John Gillard to CEO
John Gillard Named Chief Executive Officer Des Fitzgerald Named Interim Chief Financial Officer DUBLIN, Ireland, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the poin...
2023-11-28 16:14:20 ET More on Trinity Biotech Seeking Alpha’s Quant Rating on Trinity Biotech Historical earnings data for Trinity Biotech Financial information for Trinity Biotech For further details see: Trinity Biotech receives non-compliance n...
DUBLIN, Ireland, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that on November 21, 2023 the Company received n...
DUBLIN, Ireland, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, welcomes the recent decision by the High Court of Kenya. The cour...
2023-10-03 14:41:05 ET Trinity Biotech plc (TRIB) Q2 2023 Earnings Call Transcript October 3, 2023 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, Investor Relations Aris Kekedjian - Chief Executive Officer John Gillard - Chief Financial Officer ...
2023-10-03 10:46:09 ET Trinity Biotech press release ( NASDAQ: TRIB ): Q2 Total revenue for fiscal Q2, 2023 was $13.9m. Loss per ADS of 15.6 cents. Revenue outlook for Q3 is expected to be approximately $14m to $15m. In addition, order backlogs have increased sub...
DUBLIN, Ireland, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended June 30, 2023. Summa...
Trinity Biotech plc (TRIB) is expected to report $-0.07 for Q3 2023 Vicapsys Life Sciences Inc (VICP) is expected to report for quarter end 2023-06-30 Innotech Corp (INTH) is expected to report for quarter end 2023-06-30 Village Super Market Inc. Class A Common Stock (VLGEA) is expect...
Trinity Biotech plc (TRIB) is expected to report $-0.07 for Q3 2023
News, Short Squeeze, Breakout and More Instantly...
Trinity Biotech plc Company Name:
TRIB Stock Symbol:
NASDAQ Market:
DUBLIN, Ireland, May 16, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligen...
DUBLIN, Ireland, May 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received substantial additional orders for TrinS...
DUBLIN, Ireland, May 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB) a commercial stage biotechnology company focused on human di...